[Webinar] How leading-edge R&D teams are using RWE

Speakers

Senior Vice President, Scientific Research, Aetion

Senior Vice President, Scientific Engagement and Delivery, Aetion

Head of RWE, Sanofi

Chief Data Science Officer, Janssen R&D

Updates on the state of RWE in 2021, including trends in regulatory approvals and anticipated guidances this year.

Examples of how biopharma can use RWE to inform trial feasibility and design, to test lab-developed hypotheses, and to support label expansion.

How global biopharma companies are integrating RWE across their R&D teams, with insight into trends and best practices for operationalizing adoption.